Lv4
600 积分 2026-03-04 加入
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
4天前
已完结
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer
1个月前
已完结
Nivolumab plus ipilimumab versus lenvatinib or sorafenib as f irst-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial
1个月前
已完结
Osimertinib after Chemoradiotherapy in Stage III EGFR-Mutated NSCLC
2个月前
已完结
皖公网安备34019202002308
